{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:08:19Z","timestamp":1788854899195,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of the Review<\/jats:title>\n                    <jats:p>Phytocannabinoids have received attention for their therapeutic properties, however, it is unclear how they affect bone homeostasis. Additionally, increased use of cannabis and hemp-derived products have raised questions about their impact on musculoskeletal health. This review summarizes recent studies that investigate the impact of phytocannabinoids on bone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>The most well studied phytocannabinoid in relation to bone health is cannabidiol (CBD). In vitro data suggests CBD inhibits osteoclasts and promotes osteoblast activity. Rodent studies have demonstrated CBD may be useful for managing bone loss associated with osteoporosis and periodontitis, as well as reducing fracture pain and promoting healing. Recent studies suggest other phytocannabinoid isolates and extracts containing multiple phytocannabinoids have varying effects on bone. The first clinical study in this area reported that a medical cannabis product reduced markers of bone turnover in healthy adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Cannabinoids bind to receptors in the endocannabinoid system which is involved in regulation of bone metabolism. Phytocannabinoids may improve bone health; however, additional work is required to determine factors such as the optimal dose, timing, and route of administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11914-026-00982-1","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:35:09Z","timestamp":1788852909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phytocannabinoids and bone health"],"prefix":"10.1007","volume":"24","author":[{"given":"Hayley","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-2377","authenticated-orcid":false,"given":"Diana E.","family":"Roopchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"982_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107862","volume":"117","author":"TE Gaston","year":"2021","unstructured":"Gaston TE, Ampah SB, Martina Bebin E, Grayson LP, Cutter GR, Hernando K, et al. Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy. Epilepsy Behav. 2021;117:107862. https:\/\/doi.org\/10.1016\/j.yebeh.2021.107862.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"982_CR2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/epi4.12956","volume":"9","author":"RT Wechsler","year":"2024","unstructured":"Wechsler RT, Burdette DE, Gidal BE, Hyslop A, McGoldrick PE, Thiele EA, et al. Consensus panel recommendations for the optimization of EPIDIOLEX\u00ae treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Epilepsia Open. 2024;9(5):1632\u201342. https:\/\/doi.org\/10.1002\/epi4.12956.","journal-title":"Epilepsia Open"},{"key":"982_CR3","doi-asserted-by":"publisher","unstructured":"SallanSE, Zinberg NE, Frei E 3. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med. 1975;293(16):795\u20137. https:\/\/doi.org\/10.1056\/nejm197510162931603","DOI":"10.1056\/nejm197510162931603"},{"issue":"2","key":"982_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3322\/caac.21260","volume":"65","author":"JL Kramer","year":"2015","unstructured":"Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2015;65(2):109\u201322. https:\/\/doi.org\/10.3322\/caac.21260.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"982_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/14656566.7.5.607","volume":"7","author":"MP Barnes","year":"2006","unstructured":"Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother. 2006;7(5):607\u201315. https:\/\/doi.org\/10.1517\/14656566.7.5.607.","journal-title":"Expert Opin Pharmacother"},{"issue":"25","key":"982_CR6","doi-asserted-by":"publisher","first-page":"14099","DOI":"10.1021\/acs.jafc.3c06616","volume":"72","author":"DS Wishart","year":"2024","unstructured":"Wishart DS, Hiebert-Giesbrecht M, Inchehborouni G, Cao X, Guo AC, LeVatte MA, et al. Chemical composition of commercial cannabis. J Agric Food Chem. 2024;72(25):14099\u2013113. https:\/\/doi.org\/10.1021\/acs.jafc.3c06616.","journal-title":"J Agric Food Chem"},{"issue":"5","key":"982_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA Elsohly","year":"2005","unstructured":"Elsohly MA, Slade D. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 2005;78(5):539\u201348. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.011.","journal-title":"Life Sci"},{"issue":"10","key":"982_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","volume":"30","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30(10):515\u201327. https:\/\/doi.org\/10.1016\/j.tips.2009.07.006.","journal-title":"Trends Pharmacol Sci"},{"key":"982_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081919","author":"F Rossi","year":"2019","unstructured":"Rossi F, Tortora C, Punzo F, Bellini G, Argenziano M, Di Paola A, et al. The endocannabinoid\/endovanilloid system in bone: from osteoporosis to osteosarcoma. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20081919.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"982_CR10","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1111\/j.1476-5381.2011.01519.x","volume":"165","author":"LS Whyte","year":"2012","unstructured":"Whyte LS, Ford L, Ridge SA, Cameron GA, Rogers MJ, Ross RA. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. Br J Pharmacol. 2012;165(8):2584\u201397. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01519.x.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"982_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.bjp.0707593","volume":"153","author":"I Bab","year":"2008","unstructured":"Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol. 2008;153(2):182\u20138. https:\/\/doi.org\/10.1038\/sj.bjp.0707593.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"982_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","volume":"10","author":"AI Idris","year":"2009","unstructured":"Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, Baker D, et al. Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab. 2009;10(2):139\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2009.07.006.","journal-title":"Cell Metab"},{"key":"982_CR13","doi-asserted-by":"publisher","unstructured":"Idris AI, van 't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med. 2005;11(7):774\u20139. https:\/\/doi.org\/10.1038\/nm1255.","DOI":"10.1038\/nm1255"},{"issue":"3","key":"982_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1073\/pnas.0504187103","volume":"103","author":"O Ofek","year":"2006","unstructured":"Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A. 2006;103(3):696\u2013701. https:\/\/doi.org\/10.1073\/pnas.0504187103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"982_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199\u2013215. https:\/\/doi.org\/10.1038\/sj.bjp.0707442.","journal-title":"Br J Pharmacol"},{"issue":"20","key":"982_CR16","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790\u2013805. https:\/\/doi.org\/10.1111\/bph.13250.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"982_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/bab.1589","volume":"65","author":"A Sabatucci","year":"2018","unstructured":"Sabatucci A, Tortolani D, Dainese E, Maccarrone M. In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor. Biotechnol Appl Biochem. 2018;65(1):21\u20138. https:\/\/doi.org\/10.1002\/bab.1589.","journal-title":"Biotechnol Appl Biochem"},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.compbiolchem.2018.11.013","volume":"78","author":"S Vijayakumar","year":"2019","unstructured":"Vijayakumar S, Manogar P, Prabhu S, Pugazhenthi M, Praseetha PK. A pharmacoinformatic approach on Cannabinoid receptor 2 (CB2) and different small molecules: Homology modelling, molecular docking, MD simulations, drug designing and ADME analysis. Comput Biol Chem. 2019;78:95\u2013107. https:\/\/doi.org\/10.1016\/j.compbiolchem.2018.11.013.","journal-title":"Comput Biol Chem"},{"issue":"10","key":"982_CR19","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/bph.14440","volume":"176","author":"M Tham","year":"2019","unstructured":"Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br J Pharmacol. 2019;176(10):1455\u201369. https:\/\/doi.org\/10.1111\/bph.14440.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"982_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101301","volume":"23","author":"F Shahbazi","year":"2020","unstructured":"Shahbazi F, Grandi V, Banerjee A, Trant JF. Cannabinoids and cannabinoid receptors: the story so far. iScience. 2020;23(7):101301. https:\/\/doi.org\/10.1016\/j.isci.2020.101301.","journal-title":"iScience"},{"issue":"4","key":"982_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.15283\/ijsc21152","volume":"15","author":"L Li","year":"2022","unstructured":"Li L, Feng J, Sun L, Xuan YW, Wen L, Li YX, et al. Cannabidiol promotes osteogenic differentiation of bone marrow mesenchymal stem cells in the inflammatory microenvironment via the CB2-dependent p38 MAPK signaling pathway. Int J Stem Cells. 2022;15(4):405\u201314. https:\/\/doi.org\/10.15283\/ijsc21152.","journal-title":"Int J Stem Cells"},{"issue":"3","key":"982_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","volume":"126","author":"H Sharir","year":"2010","unstructured":"Sharir H, Abood ME. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther. 2010;126(3):301\u201313. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.02.004.","journal-title":"Pharmacol Ther"},{"issue":"38","key":"982_CR23","doi-asserted-by":"publisher","first-page":"16511","DOI":"10.1073\/pnas.0902743106","volume":"106","author":"LS Whyte","year":"2009","unstructured":"Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ, et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A. 2009;106(38):16511\u20136. https:\/\/doi.org\/10.1073\/pnas.0902743106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"982_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bcp.2013.11.016","volume":"87","author":"E Schmuhl","year":"2014","unstructured":"Schmuhl E, Ramer R, Salamon A, Peters K, Hinz B. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42\/44 MAPK. Biochem Pharmacol. 2014;87(3):489\u2013501. https:\/\/doi.org\/10.1016\/j.bcp.2013.11.016.","journal-title":"Biochem Pharmacol"},{"key":"982_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.900667","volume":"13","author":"K Sui","year":"2022","unstructured":"Sui K, Tveter KM, Bawagan FG, Buckendahl P, Martinez SA, Jaffri ZH, et al. Cannabidiol-treated ovariectomized mice show improved glucose, energy, and bone metabolism with a bloom in lactobacillus. Front Pharmacol. 2022;13:900667. https:\/\/doi.org\/10.3389\/fphar.2022.900667.","journal-title":"Front Pharmacol"},{"issue":"5","key":"982_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00223-024-01281-6","volume":"115","author":"AC de Oliveira","year":"2024","unstructured":"de Oliveira AC, Macedo AP, Shimano AC. Effects of cannabidiol on bone quality in ovariectomized rats. Calcif Tissue Int. 2024;115(5):700\u201311. https:\/\/doi.org\/10.1007\/s00223-024-01281-6.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"982_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf197","volume":"10","author":"K Chanpaisaeng","year":"2026","unstructured":"Chanpaisaeng K, Fleet JC, Rawiwet V, Phonsatta N, Panya A, Panupinthu N, et al. Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats. JBMR Plus. 2026;10(2):ziaf197. https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf197.","journal-title":"JBMR Plus"},{"key":"982_CR28","doi-asserted-by":"publisher","DOI":"10.1055\/a-1468-3781","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Ibrahim AK, Radwan MM, Slade D, Chandra S, Khan IA, et al. Microbial biotransformation of cannabidiol (CBD) from Cannabis sativa. Planta Med. 2021. https:\/\/doi.org\/10.1055\/a-1468-3781.","journal-title":"Planta Med"},{"issue":"6","key":"982_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s00223-023-01083-2","volume":"112","author":"R Ihejirika-Lomedico","year":"2023","unstructured":"Ihejirika-Lomedico R, Patel K, Buchalter DB, Kirby DJ, Mehta D, Dankert JF, et al. Non-psychoactive cannabidiol prevents osteoporosis in an animal model and increases cell viability, proliferation, and osteogenic gene expression in human skeletal stem and progenitor cells. Calcif Tissue Int. 2023;112(6):716\u201326. https:\/\/doi.org\/10.1007\/s00223-023-01083-2.","journal-title":"Calcif Tissue Int"},{"key":"982_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejphar.2017.05.011","volume":"809","author":"D Li","year":"2017","unstructured":"Li D, Lin Z, Meng Q, Wang K, Wu J, Yan H. Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury. Eur J Pharmacol. 2017;809:13\u20139. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.011.","journal-title":"Eur J Pharmacol"},{"key":"982_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.msec.2019.03.070","volume":"101","author":"A Kamali","year":"2019","unstructured":"Kamali A, Oryan A, Hosseini S, Ghanian MH, Alizadeh M, Baghaban Eslaminejad M, et al. Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects. Mater Sci Eng C Mater Biol Appl. 2019;101:64\u201375. https:\/\/doi.org\/10.1016\/j.msec.2019.03.070.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"982_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1124\/jpet.124.002189","volume":"391","author":"SO Vanegas","year":"2024","unstructured":"Vanegas SO, Zaki A, Dealy CN, Kinsey SG. The minor phytocannabinoid delta-8-tetrahydrocannabinol attenuates collagen-induced arthritic inflammation and pain-depressed behaviors. J Pharmacol Exp Ther. 2024;391(2):222\u201330. https:\/\/doi.org\/10.1124\/jpet.124.002189.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"982_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.spinee.2024.04.031","volume":"24","author":"H Fogel","year":"2024","unstructured":"Fogel H, Yeritsyan D, Momenzadeh K, Kheir N, Yeung CM, Abbasian M, et al. The effect of cannabinoids on single-level lumbar arthrodesis outcomes in a rat model. Spine J. 2024;24(9):1759\u201372. https:\/\/doi.org\/10.1016\/j.spinee.2024.04.031.","journal-title":"Spine J"},{"issue":"10","key":"982_CR34","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/jbmr.2513","volume":"30","author":"NM Kogan","year":"2015","unstructured":"Kogan NM, Melamed E, Wasserman E, Raphael B, Breuer A, Stok SK, et al. Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts. J Bone Miner Res. 2015;30(10):1905\u201313. https:\/\/doi.org\/10.1002\/jbmr.2513.","journal-title":"J Bone Miner Res"},{"key":"982_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117035","volume":"181","author":"SSR Nielsen","year":"2024","unstructured":"Nielsen SSR, Pedersen JAZ, Sharma N, Wasehuus PK, Hansen MS, M\u00f8ller AMJ, et al. Human osteoclasts in vitro are dose dependently both inhibited and stimulated by cannabidiol (CBD) and \u03949-tetrahydrocannabinol (THC). Bone. 2024;181:117035. https:\/\/doi.org\/10.1016\/j.bone.2024.117035.","journal-title":"Bone"},{"issue":"12","key":"982_CR36","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/tox.22996","volume":"35","author":"MA Kang","year":"2020","unstructured":"Kang MA, Lee J, Park SH. Cannabidiol induces osteoblast differentiation via angiopoietin1 and p38 MAPK. Environ Toxicol. 2020;35(12):1318\u201325. https:\/\/doi.org\/10.1002\/tox.22996.","journal-title":"Environ Toxicol"},{"key":"982_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246211","author":"M Tsuchiya","year":"2019","unstructured":"Tsuchiya M, Kayamori K, Wada A, Komaki M, Ohata Y, Hamagaki M, et al. A novel, tumor-induced osteoclastogenesis pathway insensitive to denosumab but interfered by cannabidiol. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20246211.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"982_CR38","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/jbmr.4902","volume":"38","author":"DK Khajuria","year":"2023","unstructured":"Khajuria DK, Karuppagounder V, Nowak I, Sepulveda DE, Lewis GS, Norbury CC, et al. Cannabidiol and cannabigerol, nonpsychotropic cannabinoids, as analgesics that effectively manage bone fracture pain and promote healing in mice. J Bone Miner Res. 2023;38(11):1560\u201376. https:\/\/doi.org\/10.1002\/jbmr.4902.","journal-title":"J Bone Miner Res"},{"key":"982_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2026.117850","volume":"207","author":"DK Khajuria","year":"2026","unstructured":"Khajuria DK, Wee H, Koroneos ZA, Tantawy MA, Lewis GS, Raup-Konsavage WM, et al. Cannabichromene attenuates fracture pain but impairs bone repair in a murine tibial fracture model. Bone. 2026;207:117850. https:\/\/doi.org\/10.1016\/j.bone.2026.117850.","journal-title":"Bone"},{"issue":"2","key":"982_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.intimp.2008.11.010","volume":"9","author":"MH Napimoga","year":"2009","unstructured":"Napimoga MH, Benatti BB, Lima FO, Alves PM, Campos AC, Pena-Dos-Santos DR, et al. Cannabidiol decreases bone resorption by inhibiting RANK\/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol. 2009;9(2):216\u201322. https:\/\/doi.org\/10.1016\/j.intimp.2008.11.010.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"982_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4062\/biomolther.2024.104","volume":"33","author":"SW Kim","year":"2025","unstructured":"Kim SW, Shrestha SK, Chuluunbaatar BA, Soh Y. Combination of cannabidiol with taurine synergistically treated periodontitis in rats. Biomol Ther (Seoul). 2025;33(1):203\u20139. https:\/\/doi.org\/10.4062\/biomolther.2024.104.","journal-title":"Biomol Ther (Seoul)"},{"issue":"4","key":"982_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/jre.13118","volume":"58","author":"H Chen","year":"2023","unstructured":"Chen H, Liu Y, Yu S, Li C, Gao B, Zhou X. Cannabidiol attenuates periodontal inflammation through inhibiting TLR4\/NF-\u03baB pathway. J Periodontal Res. 2023;58(4):697\u2013707. https:\/\/doi.org\/10.1111\/jre.13118.","journal-title":"J Periodontal Res"},{"key":"982_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03763-5","author":"A Makeudom","year":"2026","unstructured":"Makeudom A, Taechukorn M, Muenhong K, Danvirunhavanit P, Petchnuan J, Dechtham E, et al. Involvement of AKT\/\u03b2-catenin in enhanced osteogenesis by cannabidiol in bone stromal cells harvested from human tori. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-025-03763-5.","journal-title":"Sci Rep"},{"key":"982_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110607","author":"NB Petrescu","year":"2020","unstructured":"Petrescu NB, Jurj A, Sori\u021b\u0103u O, Lucaciu OP, Dirzu N, Raduly L, et al. Cannabidiol and vitamin D3 impact on osteogenic differentiation of human dental mesenchymal stem cells. Medicina (Kaunas). 2020. https:\/\/doi.org\/10.3390\/medicina56110607.","journal-title":"Medicina (Kaunas)"},{"key":"982_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biom13010118","author":"L Yu","year":"2023","unstructured":"Yu L, Zeng L, Zhang Z, Zhu G, Xu Z, Xia J, et al. Cannabidiol rescues TNF-\u03b1-inhibited proliferation, migration, and osteogenic\/odontogenic differentiation of dental pulp stem cells. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13010118.","journal-title":"Biomolecules"},{"issue":"1","key":"982_CR46","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s42003-024-06655-y","volume":"7","author":"F Liu","year":"2024","unstructured":"Liu F, Wu Q, Liu Q, Chen B, Liu X, Pathak JL, et al. Dental pulp stem cells-derived cannabidiol-treated organoid-like microspheroids show robust osteogenic potential via upregulation of WNT6. Commun Biol. 2024;7(1):972. https:\/\/doi.org\/10.1038\/s42003-024-06655-y.","journal-title":"Commun Biol"},{"issue":"3","key":"982_CR47","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.ajodo.2021.07.012","volume":"161","author":"KP Klein","year":"2022","unstructured":"Klein KP, Guastaldi FPS, Pereira HSG, He Y, Lukas SE. Dronabinol inhibits alveolar bone remodeling in tooth movement of rats. Am J Orthod Dentofacial Orthop. 2022;161(3):e215\u201322. https:\/\/doi.org\/10.1016\/j.ajodo.2021.07.012.","journal-title":"Am J Orthod Dentofacial Orthop"},{"issue":"6","key":"982_CR48","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1089\/can.2021.0244","volume":"8","author":"V Karuppagounder","year":"2023","unstructured":"Karuppagounder V, Chung J, Abdeen A, Thompson A, Bouboukas A, Pinamont WJ, et al. Therapeutic effects of non-euphorigenic cannabis extracts in osteoarthritis. Cannabis Cannabinoid Res. 2023;8(6):1030\u201344. https:\/\/doi.org\/10.1089\/can.2021.0244.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"982_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/ID.0b013e31818c5a2a","volume":"17","author":"R Nogueira-Filho Gda","year":"2008","unstructured":"Nogueira-Filho Gda R, Cadide T, Rosa BT, Neiva TG, Tunes R, Peruzzo D, et al. Cannabis sativa smoke inhalation decreases bone filling around titanium implants: a histomorphometric study in rats. Implant Dent. 2008;17(4):461\u201370. https:\/\/doi.org\/10.1097\/ID.0b013e31818c5a2a.","journal-title":"Implant Dent"},{"key":"982_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","volume":"38","author":"D Hasin","year":"2021","unstructured":"Hasin D, Walsh C. Trends over time in adult cannabis use: A review of recent findings. Curr Opin Psychol. 2021;38:80\u20135. https:\/\/doi.org\/10.1016\/j.copsyc.2021.03.005.","journal-title":"Curr Opin Psychol"},{"key":"982_CR51","doi-asserted-by":"publisher","unstructured":"Patrick ME, Miech RA, Johnston LD, O\u2019Malley PM. Monitoring the Future Panel. Study annual report: National data on substance use among adults ages 19 to 65, 1976\u20132023. Monitoring the Future Monograph Series. Ann Arbor, MI: Institute for Social Research, University of Michigan. 2024. https:\/\/doi.org\/10.7826\/ISR-UM.06.585140.002.07.0003.2024","DOI":"10.7826\/ISR-UM.06.585140.002.07.0003.2024"},{"issue":"1","key":"982_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11657-017-0320-9","volume":"12","author":"D Bourne","year":"2017","unstructured":"Bourne D, Plinke W, Hooker ER, Nielson CM. Cannabis use and bone mineral density: NHANES 2007\u20132010. Arch Osteoporos. 2017;12(1):29. https:\/\/doi.org\/10.1007\/s11657-017-0320-9.","journal-title":"Arch Osteoporos"},{"issue":"5","key":"982_CR53","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/19390211.2020.1765941","volume":"17","author":"HL Lopez","year":"2020","unstructured":"Lopez HL, Cesareo KR, Raub B, Kedia AW, Sandrock JE, Kerksick CM, et al. Effects of hemp extract on markers of wellness, stress resilience, recovery and clinical biomarkers of safety in overweight, but otherwise healthy subjects. J Diet Suppl. 2020;17(5):561\u201386. https:\/\/doi.org\/10.1080\/19390211.2020.1765941.","journal-title":"J Diet Suppl"},{"issue":"2","key":"982_CR54","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.amjmed.2016.07.034","volume":"130","author":"A Sophocleous","year":"2017","unstructured":"Sophocleous A, Robertson R, Ferreira NB, McKenzie J, Fraser WD, Ralston SH. Heavy cannabis use is associated with low bone mineral density and an increased risk of fractures. Am J Med. 2017;130(2):214\u201321. https:\/\/doi.org\/10.1016\/j.amjmed.2016.07.034.","journal-title":"Am J Med"},{"issue":"S1","key":"982_CR55","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1089\/can.2023.0060","volume":"8","author":"J Kulpa","year":"2023","unstructured":"Kulpa J, Harrison A, Rudolph L, Eglit GML, Turcotte C, Bonn-Miller MO, et al. Oral cannabidiol treatment in two postmenopausal women with osteopenia: a case series. Cannabis Cannabinoid Res. 2023;8(S1):S83\u20139. https:\/\/doi.org\/10.1089\/can.2023.0060.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"982_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1089\/can.2022.0181","volume":"9","author":"J Kulpa","year":"2024","unstructured":"Kulpa J, Eglit G, Hill ML, MacNair L, Yardley H, Ware MA, et al. Serum markers of bone turnover following controlled administration of two medical cannabis products in healthy adults. Cannabis Cannabinoid Res. 2024;9(1):300\u20139. https:\/\/doi.org\/10.1089\/can.2022.0181.","journal-title":"Cannabis Cannabinoid Res"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-026-00982-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:35:10Z","timestamp":1788852910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-026-00982-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s11914-026-00982-1","relation":{},"ISSN":["1544-2241"],"issn-type":[{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DER has equity in Nutrasorb LLC. The authors declare no other competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"36"}}